BPCE
REGN icon

Bank Pictet & Cie (Europe)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-845
Closed -$316K – 162
2018
Q4 		$316K Sell
845
-200
-19% -$73.2K 0.06% 119
2018
Q3 		$422K Sell
1,045
-80
-7% -$30.4K 0.06% 135
2018
Q2 		$388K Sell
1,125
-361
-24% -$113K 0.06% 125
2018
Q1 		$512K Buy
1,486
+188
+14% +$65.4K 0.08% 110
2017
Q4 		$488K Buy
1,298
+288
+29% +$117K 0.07% 122
2017
Q3 		$452K Buy
+1,010
New +$481K 0.06% 141

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s REGN Position: Q1 2019 in Review

Bank Pictet & Cie (Europe) sold out of Regeneron Pharmaceuticals (REGN) in Q1 2019, closing a stake of 845 shares — an estimated $316K sold.

Bank Pictet & Cie (Europe) first reported a position in REGN in Q3 2017 and held it in 6 quarters. The position peaked at $512K in Q1 2018. 719 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

  • Bank Pictet & Cie (Europe) reported no remaining Regeneron Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 845 Regeneron Pharmaceuticals shares in Q1 2019, an estimated $316K.
  • Bank Pictet & Cie (Europe) first reported a position in Regeneron Pharmaceuticals in Q3 2017 and held it in 6 quarters.
  • Bank Pictet & Cie (Europe)'s Regeneron Pharmaceuticals position peaked at $512K in Q1 2018.
  • 719 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2019, filed 1 May 2019.